probenecid has been researched along with bumetanide in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (27.27) | 18.7374 |
1990's | 3 (9.09) | 18.2507 |
2000's | 8 (24.24) | 29.6817 |
2010's | 13 (39.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foguet, M; Hagenbuch, B; Lübbert, H; Meier, PJ; Stieger, B | 1 |
Grassl, SM; Holtzman, EJ; Race, JE; Williams, WJ | 1 |
Cha, SH; Endou, H; Kanai, Y; Kojima, R; Kusuhara, H; Sekine, T; Sugiyama, Y; Tsuda, M; Utsunomiya-Tate, N | 1 |
Strassburg, CP; Tukey, RH | 1 |
Topliss, JG; Yoshida, F | 1 |
Cha, SH; Endou, H; Fukushima , JI; Goya, T; Kanai, Y; Kobayashi, Y; Sekine, T | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Holland, SD; Williamson, HE | 1 |
Lant, AF | 1 |
Sandström, PE | 1 |
Griffiths, NM; Simmons, NL | 1 |
Bekersky, I; Popick, AC | 1 |
Lau, HS; Shih, LJ; Smith, DE | 1 |
Beermann, B; Lindström, B; Odlind, B | 1 |
Lau, HS; Smith, DE | 1 |
Brater, DC; Chennavasin, P | 1 |
Burckhardt, BC; Burckhardt, G; Wolff, NA | 1 |
Brandt, C; Löscher, W; Römermann, K; Töllner, K | 1 |
Boylan, GB; Cryan, JF; Donovan, MD; Griffin, BT; O'Brien, FE | 1 |
Erker, T; Fedrowitz, M; Hampel, P; Kaczmarek, E; Löscher, W; Römermann, K; Sweet, DH; Töllner, K | 1 |
3 review(s) available for probenecid and bumetanide
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for probenecid and bumetanide
Article | Year |
---|---|
Effects of bumetanide on cation and anion transport.
Topics: Biological Transport, Active; Bumetanide; Clinical Trials as Topic; Diuresis; Diuretics; Humans; Kidney; Natriuresis; Nephrons; Osmolar Concentration; Probenecid; Water-Electrolyte Balance | 1975 |
29 other study(ies) available for probenecid and bumetanide
Article | Year |
---|---|
Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system.
Topics: Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Carrier Proteins; Cloning, Molecular; DNA; Female; Gene Library; Liver; Molecular Sequence Data; Molecular Weight; Oocytes; Organic Anion Transporters, Sodium-Dependent; Protein Conformation; Rats; Restriction Mapping; RNA, Messenger; Sodium; Symporters; Taurocholic Acid; Xenopus laevis | 1991 |
Molecular cloning and characterization of two novel human renal organic anion transporters (hOAT1 and hOAT3).
Topics: Amino Acid Sequence; Animals; Anion Transport Proteins; Biological Transport; Blotting, Northern; Carrier Proteins; Chromosomes, Human, Pair 11; Cloning, Molecular; Humans; Kidney; Mice; Molecular Sequence Data; Oocytes; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Rats; Sequence Homology, Amino Acid; Xenopus laevis | 1999 |
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.
Topics: Amino Acid Sequence; Animals; Brain; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Estrone; Molecular Sequence Data; Ochratoxins; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Xenopus laevis | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Chromosome Mapping; Chromosomes, Human, Pair 11; Cloning, Molecular; Gene Library; Humans; Kidney Tubules, Proximal; Molecular Sequence Data; Oocytes; Organic Anion Transporters, Sodium-Independent; Sequence Homology, Amino Acid; Tissue Distribution; Transfection; Xenopus laevis | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Probenecid inhibition of bumetanide-induced natriuresis in the dog.
Topics: Animals; Bumetanide; Diuresis; Diuretics; Dogs; Female; Infusions, Intra-Arterial; Kidney; Male; Natriuresis; Probenecid; Renal Artery | 1979 |
Evidence for diabetogenic action of bumetanide in mice.
Topics: Animals; Blood Glucose; Body Weight; Bumetanide; Diabetes Mellitus, Experimental; Diuresis; Diuretics; Glucose Tolerance Test; Insulin; Insulin Secretion; Mice; Probenecid | 1988 |
Attribution of [3H]bumetanide binding to the Na+K+Cl 'co-transporter' in rabbit renal cortical plasma membranes: a caveat.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Binding Sites; Binding, Competitive; Bumetanide; Cell Membrane; Cells, Cultured; Diuretics; Female; Kidney Cortex; Kidney Medulla; Kinetics; Male; Probenecid; Rabbits; Radioligand Assay | 1987 |
Disposition of bumetanide in the isolated perfused rat kidney: effects of probenecid and dose response.
Topics: Animals; Biological Transport; Bumetanide; Diuresis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Kidney; Kinetics; Male; Perfusion; Probenecid; Rats | 1986 |
Effect of probenecid on the dose-response relationship of bumetanide at steady state.
Topics: Animals; Bumetanide; Diuresis; Diuretics; Dogs; Dose-Response Relationship, Drug; Kidney; Male; Natriuresis; Probenecid | 1983 |
Coupling between renal tubular secretion and effect of bumetanide.
Topics: Adult; Bumetanide; Chlorides; Diuresis; Diuretics; Drug Interactions; Humans; Infusions, Parenteral; Kidney Tubules; Male; Metabolic Clearance Rate; Probenecid | 1983 |
Determinants of bumetanide response in the dog: effect of probenecid.
Topics: Animals; Bumetanide; Diuresis; Diuretics; Dogs; Drug Interactions; Kidney; Kinetics; Male; Natriuresis; Probenecid | 1983 |
Effect of probenecid on response to bumetanide in man.
Topics: Adult; Bumetanide; Diuretics; Drug Interactions; Humans; Kidney; Male; Natriuresis; Potassium; Probenecid | 1981 |
Electrophysiologic characterization of an organic anion transporter cloned from winter flounder kidney (fROAT).
Topics: Animals; Anion Transport Proteins; Biological Transport, Active; Bumetanide; Carrier Proteins; Cells, Cultured; Clone Cells; Dicarboxylic Acid Transporters; Diuretics; Dose-Response Relationship, Drug; Escherichia coli Proteins; Flounder; Furosemide; Kidney Tubules, Proximal; Membrane Potentials; Membrane Transport Proteins; Oocytes; p-Aminohippuric Acid; Patch-Clamp Techniques; Probenecid; Substrate Specificity; Xenopus laevis | 2000 |
The organic anion transport inhibitor probenecid increases brain concentrations of the NKCC1 inhibitor bumetanide.
Topics: Animals; Animals, Outbred Strains; Anticonvulsants; Biological Transport; Blood-Brain Barrier; Brain; Bumetanide; Cell Line; Diuretics; Dogs; Drug Interactions; Female; Half-Life; Humans; Kidney; Membrane Transport Modulators; Mice; Nerve Tissue Proteins; Neurons; Organic Anion Transporters; Probenecid; Recombinant Proteins; Sodium Potassium Chloride Symporter Inhibitors | 2015 |
The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat.
Topics: Adjuvants, Pharmaceutic; Animals; Biological Transport; Blood-Brain Barrier; Bumetanide; Drug Interactions; Extracellular Fluid; GABA Agents; Hippocampus; Male; Microdialysis; Organic Anion Transporters; Probenecid; Rats, Sprague-Dawley | 2015 |
Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain.
Topics: Animals; Biological Transport; Blood-Brain Barrier; Brain; Bumetanide; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Diffusion; Female; Membrane Transport Modulators; Mice; Multidrug Resistance-Associated Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Organic Cation Transport Proteins; Probenecid | 2017 |